news & events
portfolio news
16.07.19
AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury
26.06.19
Sanifit announces €72.2M ($80.9M) financing in Spain’s largest private biotech fundraise
04.06.19
Rainier Therapeutics Announces Presentation of Patient Biopsy Data Demonstrating Vofatamab’s Ability to Increase Immune Cell Activation
04.06.19
Minoryx Therapeutics announces first patient dosed in the FRAMES phase 2 trial in Friedreich’s Ataxia
03.06.19
Rainier Therapeutics Announces Results from First Interim Analysis of the FIERCE-22 Trial of Vofatamab in Combination with Pembrolizumab in Patients with Metastatic Urothelial Cell Carcinoma (Bladder Cancer)
02.04.19
Aura Biosciences Completes $40 Million Series D Financing
20.03.19
Pfizer secures exclusive option to acquire gene therapy company vivet therapeutics
27.02.19
Minoryx Therapeutics receives approval from Spanish Regulatory Agency to initiate phase 2 study in Friedreich’s Ataxia
15.01.19
Minoryx Therapeutics extends its activities in Belgium
28.11.18
BioClin Therapeutics Announces Name Change to Rainier Therapeutics
